Literature DB >> 3489034

IgA-driven T cell-mediated anti-bacterial immunity in man after live oral Ty 21a vaccine.

A Tagliabue, L Villa, M T De Magistris, M Romano, S Silvestri, D Boraschi, L Nencioni.   

Abstract

Cellular immunity against Salmonella typhi was observed by using a direct anti-bacterial in vitro assay in volunteers orally vaccinated with the live S. typhi mutant strain Ty 21a. With this experimental approach, it was demonstrated that Ty 21a vaccine also induces cellular immunity against S. paratyphi A and B. Interestingly, the mechanism involved in cellular immunity against bacteria seems to be of an antibody-dependent cellular cytotoxicity (ADCC) type, with IgA acting as the humoral arm and CD4+ T lymphocytes as the cellular one. In accordance with the increase in IgA-driven ADCC against S. typhi, a major rise in IgA against O and H antigens was observed in the serum of vaccinees in parallel to an increase in IgG of identical specificity. Furthermore, a Ty 21 vaccine induced cellular activity against flagellar antigens. These results indicate that IgA-ADCC by T lymphocytes against bacteria can originate from local stimulation of the gut mucosal immune system. This cellular defense mechanism might be at the origin of the protection induced by Ty 21a vaccine.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3489034

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  23 in total

Review 1.  Immunity to murine chlamydial genital infection.

Authors:  Richard P Morrison; Harlan D Caldwell
Journal:  Infect Immun       Date:  2002-06       Impact factor: 3.441

2.  The specificity of the human neutrophil IgA receptor (Fc alpha R) determined by measurement of chemiluminescence induced by serum or secretory IgA1 or IgA2.

Authors:  W W Stewart; M A Kerr
Journal:  Immunology       Date:  1990-11       Impact factor: 7.397

Review 3.  Antibodies and Protection in Systemic Salmonella Infections: Do We Still Have More Questions than Answers?

Authors:  Pietro Mastroeni; Omar Rossi
Journal:  Infect Immun       Date:  2020-09-18       Impact factor: 3.441

4.  Oral immunization against Helicobacter pylori.

Authors:  S J Czinn; J G Nedrud
Journal:  Infect Immun       Date:  1991-07       Impact factor: 3.441

5.  Antibodies in action: role of human opsonins in killing Salmonella enterica serovar Typhi.

Authors:  Janet C Lindow; Kelly A Fimlaid; Janice Y Bunn; Beth D Kirkpatrick
Journal:  Infect Immun       Date:  2011-05-31       Impact factor: 3.441

6.  Constitutive expression of the Vi polysaccharide capsular antigen in attenuated Salmonella enterica serovar typhi oral vaccine strain CVD 909.

Authors:  J Y Wang; F R Noriega; J E Galen; E Barry; M M Levine
Journal:  Infect Immun       Date:  2000-08       Impact factor: 3.441

7.  Oral immunization with a Salmonella enterica serovar typhi vaccine induces specific circulating mucosa-homing CD4(+) and CD8(+) T cells in humans.

Authors:  B Samuel Lundin; Camilla Johansson; Ann-Mari Svennerholm
Journal:  Infect Immun       Date:  2002-10       Impact factor: 3.441

8.  Live oral Salmonella enterica serovar Typhi vaccines Ty21a and CVD 909 induce opsonophagocytic functional antibodies in humans that cross-react with S. Paratyphi A and S. Paratyphi B.

Authors:  Rezwanul Wahid; Shah J Zafar; Monica A McArthur; Marcela F Pasetti; Myron M Levine; Marcelo B Sztein
Journal:  Clin Vaccine Immunol       Date:  2014-01-15

9.  Comparative analysis of immunological responses to oral (Ty21a) and parenteral (TAB) typhoid vaccines.

Authors:  R D'Amelio; A Tagliabue; L Nencioni; A Di Addario; L Villa; M Manganaro; D Boraschi; S Le Moli; R Nisini; P M Matricardi
Journal:  Infect Immun       Date:  1988-10       Impact factor: 3.441

10.  Human Toxoplasma gondii-specific secretory immunoglobulin A reduces T. gondii infection of enterocytes in vitro.

Authors:  D G Mack; R McLeod
Journal:  J Clin Invest       Date:  1992-12       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.